Pharmaceuticals company GlaxoSmithKline has appointed Cardano as investment adviser to assets worth £10 billion owned by its final salary pension scheme.

Cardano, an Anglo-Dutch investment consultant, is taking over the contract from Aon Hewitt, which confirmed the loss, although it added that it had retained some actuarial work.